Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Ascend Wellness Holdings, Inc.

Ticker
AAWH
Sector
Industry
Report date
November 12, 2026
Valye AI Score

94

Very high visibility
Recent developments
Recent developments summary

Recent news coverage includes Ascend Wellness Holdings reporting a Q1 2026 loss with revenue exceeding estimates, reflecting ongoing operational challenges amid regulatory developments in the cannabis industry.

Recent developments:
  • Ascend Wellness Holdings reported a Q1 2026 loss but topped revenue estimates, indicating revenue growth despite profitability challenges [N8].
Overview

Ascend Wellness Holdings, Inc. is a vertically integrated cannabis company operating in seven U.S. states with a focus on adult-use or near-term adult-use markets in limited license states. The company cultivates, manufactures, and distributes cannabis products including flower, pre-rolls, concentrates, vapes, edibles, and tablets. Ascend sells products through its own retail stores, retail partner locations, and third-party licensed retailers. The company operates cultivation facilities with approximately 258,000 square feet of canopy and maintains a portfolio of in-house brands such as Ozone, Simply Herb, High Wired, Honor Roll, Royale, and Effin'. Ascend has grown through acquisitions and maintains a complex organizational structure to comply with state-specific licensing requirements. The company reported $130 million in revenue for Q3 2026 and had $63.6 million in cash and equivalents as of September 30, 2026. Regulatory risks include federal cannabis scheduling and uncertainty around DEA registration for medical cannabis operators.

Executive summary

Ascend Wellness Holdings, Inc. is a vertically integrated multi-state cannabis operator focused on adult-use and near-term adult-use markets in limited license states. The company cultivates, manufactures, and distributes cannabis consumer packaged goods through company-owned retail stores, retail partner locations, and third-party licensed retailers across seven U.S. states. As of September 30, 2026, Ascend reported $130 million in quarterly revenue, with a net loss reflected in prior fiscal year results. The company operates cultivation facilities totaling approximately 258,000 square feet of canopy and maintains a diversified product portfolio under multiple in-house brands. Ascend's financial position as of September 30, 2026 includes $63.6 million in cash and equivalents and a current ratio of 1.56. The company faces regulatory risks related to federal cannabis scheduling and DEA registration pathways. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for AAWH

Bull case model:

Ascend's vertically integrated operations across multiple adult-use cannabis markets and diversified product portfolio position it to serve a broad consumer base. The company's expansion plans targeting 60 retail locations and cultivation canopy growth support scaling opportunities. Established in-house brands with market recognition and strategic acquisitions enhance market penetration. Potential benefits from federal cannabis rescheduling and DEA registration pathways for medical cannabis could reduce regulatory burdens and improve operational efficiencies. Strong liquidity and refinancing of debt provide financial flexibility to support growth initiatives.

Bear case model:

Ascend faces significant regulatory risks due to the federal illegality of adult-use cannabis and uncertainties surrounding the April 2026 DOJ order and DEA registration processes. The company's financial results include net losses and negative earnings per share, reflecting ongoing challenges in achieving profitability. Market competition in limited-license states and pressures in wholesale markets may impact revenue growth. The complex organizational structure and capital-intensive expansion plans require effective execution amid evolving regulatory and economic conditions. Potential tax audit challenges related to cost allocations between medical and adult-use operations add financial risk.

Moat:

Ascend Wellness Holdings benefits from a vertically integrated business model spanning cultivation, manufacturing, and retail distribution across multiple limited-license adult-use cannabis markets. Its multi-state footprint and diversified product portfolio under established in-house brands provide competitive positioning. The company's growth through strategic acquisitions and partnerships with social equity license holders supports market presence. Complex state-specific licensing and regulatory compliance requirements create barriers to entry for competitors. However, ongoing federal regulatory uncertainty and the evolving cannabis market landscape present challenges to sustaining competitive advantages.

Risks overview
Risks summary
Regulatory and legal uncertainties related to federal cannabis scheduling and DEA registration pose the most significant risks to Ascend's business operations and financial performance.
Risks details:

• Regulatory and Legal Risks: Federal cannabis illegality for adult-use operations creates operational, regulatory, and legal uncertainties. The April 2026 DOJ order rescheduling medical cannabis to Schedule III does not cover adult-use cannabis, limiting potential benefits. The DEA registration pathway for medical cannabis operators is uncertain in timing and terms, with ongoing litigation risks.
• Financial Performance Risks: The company has reported net losses and negative earnings per share, indicating challenges in achieving profitability. Market pressures and competition in adult-use cannabis markets may affect revenue and margins.
• Operational Execution Risks: Expansion plans including opening new retail locations and cultivation facilities require capital allocation and effective execution. Complex state-specific licensing and organizational structure add operational complexity.

FINAL FORECAST FOR AAWH

Final take one line
Ascend Wellness Holdings operates a vertically integrated multi-state cannabis business with detailed disclosures on its operations, financials, and regulatory risks, providing very high visibility into its business model.
Final take 12 to 24 month view

Business trends: Expansion in adult-use cannabis markets with diversified product portfolio and retail footprint growth.
Execution milestones: Opening new retail locations, cultivation expansions, and navigating regulatory pathways including DEA registration.
Key risks: Federal cannabis regulatory uncertainty, operational complexity, and ongoing challenges in achieving profitability.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

94
LLM visibility overview
LLM Visibility known facts
  • Ascend Wellness Holdings, Inc. is a vertically integrated multi-state cannabis operator focused on adult-use or near-term adult-use states in primarily limited license markets [S1].
  • The company's core business includes cultivation, manufacturing, and distribution of cannabis consumer packaged goods sold through company-owned retail stores, retail partner locations, and third-party licensed retail locations [S1].
  • Ascend operates in seven U.S. geographic markets: Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania [S1].
  • As of December 31, 2025, the company had 47 open dispensaries, with 42 in states permitting adult-use cannabis, and targets 60 total retail locations including retail partner locations [S1].
  • Ascend operates cultivation facilities in six states with approximately 258,000 square feet of total canopy [S1].
  • The company produces multiple cannabis product categories including flower, pre-rolls, infused pre-rolls, concentrates, vapes, edibles, and tablets [S1].
  • Ascend's in-house brands include Ozone, Simply Herb, High Wired, Honor Roll, Royale, and Effin', each targeting different consumer segments and markets [S1].
  • The company had approximately 206.5 million diluted shares outstanding as of December 31, 2025 [S1].
  • Ascend has a history of growth through acquisitions of dispensaries, cultivation, and processing facilities across multiple states [S1].
  • The company has financing history including a 2021 credit facility and issuance of senior secured notes in 2024 and 2025 to fund growth and refinance debt [S1].
  • Financial snapshot as of September 30, 2026: cash and equivalents of $63.6 million, current assets of $181.2 million, current liabilities of $116.3 million, current ratio of 1.56, and cash ratio of 0.55 [S2].
  • Revenue for the quarter ending September 30, 2026 was $130.0 million [S2].
  • Basic and diluted EPS for the quarter ending September 30, 2026 were both -$0.14 [S2].
  • The company reported a net loss of $80.9 million for the fiscal year ended December 31, 2022 [S1].
  • Ascend is subject to regulatory risks related to federal cannabis laws, including the April 2026 DOJ order rescheduling certain medical cannabis to Schedule III, which does not cover adult-use cannabis and may have limited benefits for the company [S2].
  • The company is evaluating the implications of DEA registration pathways for medical cannabis operators but faces uncertainty regarding timing and terms [S2].
  • Ascend's business and financial results have been reported in recent news, including Q1 2026 loss with revenue exceeding estimates [N8].
Sources
Sources - Context summary

Generated 2026-11-13

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-12 | 10-K
  • S2 | 2026-11-12 | 10-Q
Sources - News headlines
  • N1 | 2026-11-13 | www.nasdaq.com | Stocks Settle Lower on Nvidia Rout and Higher Crude and Bond Yields | https://www.nasdaq.com/articles/stocks-settle-lower-nvidia-rout-and-higher-crude-and-bond-yields
  • N2 | 2026-11-13 | www.nasdaq.com | EyePoint Reports Third Quarter 2026 Financial Results and Provides Recent Corporate Developments | https://www.nasdaq.com/articles/eyepoint-reports-third-quarter-2026-financial-results-and-provides-recent-corporate
  • N3 | 2026-11-13 | www.nasdaq.com | Soybeans Retreat on Thursday, Despite Export Business | https://www.nasdaq.com/articles/soybeans-retreat-thursday-despite-export-business
  • N4 | 2026-11-13 | www.nasdaq.com | Cattle Post Gains as Feeders Power Higher | https://www.nasdaq.com/articles/cattle-post-gains-feeders-power-higher
  • N5 | 2026-11-13 | www.nasdaq.com | MediWound Reports Third Quarter 2026 Financial Results and Provides Corporate Update | https://www.nasdaq.com/articles/mediwound-reports-third-quarter-2026-financial-results-and-provides-corporate-update
  • N6 | 2026-11-13 | www.nasdaq.com | Kontoor Brands, Inc. Enters Into $400 million Accelerated Share Repurchase Agreements | https://www.nasdaq.com/articles/kontoor-brands-inc-enters-400-million-accelerated-share-repurchase-agreements
  • N7 | 2026-11-13 | www.nasdaq.com | Pharvaris N.V. Reports Third Quarter 2026 Financial Results | https://www.nasdaq.com/articles/pharvaris-nv-reports-third-quarter-2026-financial-results
  • N8 | 2026-05-13 | www.nasdaq.com | Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Tops Revenue Estimates | https://www.nasdaq.com/articles/ascend-wellness-holdings-inc-aawh-reports-q1-loss-tops-revenue-estimates
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine